uniQure N.V. Unrecognized Tax Benefits, Interest on Income Taxes Expense
uniQure N.V. (QURE) reported Unrecognized Tax Benefits, Interest on Income Taxes Expense of -$1.10 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense · last filed 2025-11-10
- uniQure N.V. unrecognized tax benefits, interest on income taxes expense for the quarter ending 2025-09-30 was -$1.10M.
| Period end | Unrecognized Tax Benefits, Interest on Income Taxes Expense 3 month | Unrecognized Tax Benefits, Interest on Income Taxes Expense 9 month |
|---|---|---|
| 2025-09-30 | -$1.10M 10-Q · filed 2025-11-10 | -$1.10M 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |